Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 1

Interventions

Cyclophosphamide 4Sirolimus 2Magnetic Resonance Spectroscopy 2Etoposide 2venetoclax 1fludarabine phosphate 1fludarabine 1etoposide phosphate 1daratumumab 1copanlisib 1alovudine 1X-Rays 1Whole-Body Irradiation 1Vincristine 1Transplantation Conditioning 1Transplantation 1Stem Cell Transplantation 1Spinal Puncture 1Specimen Handling 1Pneumococcal Vaccines 1Photopheresis 1Phantoms, Imaging 1Peripheral Blood Stem Cell Transplantation 1Pemetrexed 1Mycophenolic Acid 1Methotrexate 1Mesna 1Mesenchymal Stem Cell Transplantation 1Leukapheresis 1Influenza Vaccines 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Precursor Cell Lymphoblastic Leukemia-Lymphoma × Transplantation Conditioning × Clear all
NCT06735690 2026-04-27

Allogeneic CMV-Specific CD19-CAR T Cells Plus CMV-MVA Triplex Vaccine After Matched Related Donor Hematopoietic Cell Transplant for the Treatment of Patients With High-Risk Acute Lymphoblastic Leukemia

City of Hope Medical Center

Phase EARLY_PHASE1 Recruiting
15 enrolled
LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡